ABPI chief exec backs Novartis legal challenge to off-label Avastin - PMLiVE
Novartis' new macular degeneration drug has to compete against colon cancer drug Avastin. Why? < Pharma < 기사본문 - KBR
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open- label, phase 3 trial - The Lancet
Avastin biosimilar may bring insurance benefits for Tecentriq < Pharma < 기사본문 - KBR
FDA Says Avastin Not Safe or Effective for Patients With Breast Cancer
Fake version cancer drug Avastin found in U.S. - New York Daily News
Avastin Lawsuits - Off-Label Use, Eye Infection, Blindness Risk
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology
PDF) Off-label use of bevacizumab for wet age-related macular degeneration in Europe
NHS wins legal fight with pharma over off-label Avastin - PMLiVE
EFPIA Files Complaint Against French Law Promoting Off-Label Avastin Use – Policy & Medicine
Avastin, Lucentis & Zaltrap, Eylea - ppt download
MHRA clarifies position on off-label Avastin - PharmaTimes
Genentech: Statements | Genentech Statement on Counterfeit Drug Labeled as Avastin® (Bevacizumab) in the United States
Immunotherapy Regimen Approved for Hepatocellular Carcinoma - MPR
SecuringIndustry.com - More fake Avastin found, this time in Cyprus
Avastin now available in UK for ovarian cancer | Pharmafile
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial - The Lancet Oncology
Avastin - FDA prescribing information, side effects and uses
File:Bevacizumab label 01.jpg - wikidoc
PDF) Bevacizumab: Off-label use in ophthalmology
Avastin Injections Are Said to Cause Blindness - The New York Times
10. Avastin | FiercePharma
